Avalo Therapeutics Inc (AVTX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
829,656,000
EV to revenue ratio (TTM)
7,127.2
EV to ebitda
-0.189
Financial Performance
Revenue (TTM)
59,000
Gross profit (TTM)
-47,893,000
EBITDA
-91,251,000
Profitability
Operating margin (TTM)
-154,847.00%
Profit margin
0.00%
Return on assets (TTM)
-18.50%
Return on equity (TTM)
-36.30%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-4.41
Diluted EPS (TTM)
-4.41
Book value
8.48
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
14,061.97
Price to book ratio (TTM)
1.829
Growth
Quarterly earnings growth (YoY)
-69.30%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
2
Buy
13
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.793